BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Sustained virologic response
1
Effectiveness and safety of generic and brand direct acting antivirals for the treatment of chronic hepatitis C
12/2/2022 12:50:19 PM | Browse: 189 | Download: 531
2
Best therapy for the easiest to treat hepatitis C virus genotype 1b-infected patients
12/2/2022 9:49:51 AM | Browse: 223 | Download: 491
3
Hepatocellular carcinoma, decompensation, and mortality based on hepatitis C treatment: A prospective cohort study
8/10/2022 8:23:14 AM | Browse: 256 | Download: 729
4
Hepatitis C virus burden: Treating and educating people without prejudice
7/27/2022 1:17:38 PM | Browse: 256 | Download: 608
5
Benign course of residual inflammation at end of treatment of liver transplant recipients after sofosbuvir based therapy
3/24/2022 2:13:21 PM | Browse: 332 | Download: 973
6
Real-world effectiveness of direct-acting antivirals in people living with human immunodeficiency virus and hepatitis C virus genotype 6 infections
3/17/2022 3:25:03 AM | Browse: 272 | Download: 502
7
Association between direct-acting antiviral agents in hepatitis C virus treatment and hepatocellular carcinoma occurrence and recurrence: The endless debate
2/23/2022 3:51:55 PM | Browse: 294 | Download: 846
8
Direct-acting antivirals for chronic hepatitis C treatment: The experience of two tertiary university centers in Brazil
1/21/2022 8:16:14 AM | Browse: 372 | Download: 610
9
Dynamics of cytokines predicts risk of hepatocellular carcinoma among chronic hepatitis C patients after viral eradication
12/31/2021 12:21:18 PM | Browse: 489 | Download: 1198
10
Hepatocellular carcinoma risk after viral response in hepatitis C virus-advanced fibrosis: Who to screen and for how long?
10/27/2021 7:14:11 AM | Browse: 406 | Download: 742
11
Recently acquired hepatitis C virus infection among people living with human immunodeficiency virus at a university hospital in Taiwan
9/29/2021 11:12:00 AM | Browse: 342 | Download: 729
12
Factors influencing the failure of interferon-free therapy for chronic hepatitis C: Data from the Polish EpiTer-2 cohort study
5/10/2021 7:46:10 AM | Browse: 309 | Download: 729
13
Metabolic and cardiovascular complications after virological cure in hepatitis C: What awaits beyond
4/29/2021 2:12:02 AM | Browse: 332 | Download: 629
14
M2BPGi for assessing liver fibrosis in patients with hepatitis C treated with direct-acting antivirals
6/6/2020 2:43:56 PM | Browse: 958 | Download: 1544
15
Sustained virologic response to direct-acting antiviral agents predicts better outcomes in hepatitis C virus-infected patients: A retrospective study
10/28/2019 11:23:12 AM | Browse: 843 | Download: 1672
16
Consensus on management of hepatitis C virus infection in resource-limited Ukraine and Commonwealth of Independent States regions
8/7/2019 7:09:17 AM | Browse: 940 | Download: 1366
17
Hepatitis C virus cure with direct-acting antivirals: Clinical, economic, societal and patient value for China
5/27/2019 8:24:36 AM | Browse: 878 | Download: 1394
18
Hepatitis C virus-associated hepatocellular carcinoma after sustained virologic response
12/27/2018 9:28:07 AM | Browse: 835 | Download: 1099
19
Factors associated with success of telaprevir- and boceprevir-based triple therapy for hepatitis C virus infection
4/13/2017 3:45:15 PM | Browse: 1189 | Download: 1929
20
Hepatitis C virus therapy with peg-interferon and ribavirin in Myanmar: A resource-constrained country
11/18/2016 3:13:00 PM | Browse: 973 | Download: 1922
21
Boceprevir plus peginterferon/ribavirin for treatment of chronic hepatitis C in Russia
2/22/2016 3:38:00 PM | Browse: 1029 | Download: 1925
22
Treatment strategies for chronic hepatitis C prior to and following liver transplantation
1/7/2016 12:14:00 PM | Browse: 1009 | Download: 1420
23
Update on hepatitis C: Direct-acting antivirals
12/4/2015 3:24:00 PM | Browse: 1047 | Download: 1711
24
Is the use of IL28B genotype justified in the era of interferon-free treatments for hepatitis C?
8/13/2015 10:30:00 AM | Browse: 1128 | Download: 1502
25
Interferon-λ polymorphisms and response to pegylated interferon in Iranian hepatitis C patients
8/8/2015 3:25:00 PM | Browse: 1021 | Download: 1937
26
Predictive factors associated with hepatitis C antiviral therapy response
6/29/2015 5:40:00 PM | Browse: 1039 | Download: 1511
27
Interferon-3 polymorphisms in pegylated-interferon- plus ribavirin therapy for genotype-2 chronic hepatitis C
4/7/2015 6:08:00 PM | Browse: 932 | Download: 1518
28
Sofosbuvir and ABT-450: Terminator of hepatitis C virus?
9/16/2014 9:54:00 AM | Browse: 1225 | Download: 1090
Write to the Help Desk
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345